Advertisement
UK markets close in 41 minutes
  • FTSE 100

    7,813.42
    -152.11 (-1.91%)
     
  • FTSE 250

    19,361.82
    -337.07 (-1.71%)
     
  • AIM

    740.05
    -10.23 (-1.36%)
     
  • GBP/EUR

    1.1704
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2449
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    50,187.35
    -1,712.05 (-3.30%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,051.06
    -10.76 (-0.21%)
     
  • DOW

    37,809.38
    +74.27 (+0.20%)
     
  • CRUDE OIL

    85.28
    -0.13 (-0.15%)
     
  • GOLD FUTURES

    2,386.90
    +3.90 (+0.16%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     
  • DAX

    17,747.00
    -279.58 (-1.55%)
     
  • CAC 40

    7,916.84
    -128.27 (-1.59%)
     

ECO Animal Health Group plc (LON:EAH) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

With its stock down 15% over the past three months, it is easy to disregard ECO Animal Health Group (LON:EAH). But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Particularly, we will be paying attention to ECO Animal Health Group's ROE today.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

View our latest analysis for ECO Animal Health Group

How Do You Calculate Return On Equity?

The formula for return on equity is:

ADVERTISEMENT

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for ECO Animal Health Group is:

13% = UK£13m ÷ UK£97m (Based on the trailing twelve months to September 2021).

The 'return' is the yearly profit. Another way to think of that is that for every £1 worth of equity, the company was able to earn £0.13 in profit.

What Has ROE Got To Do With Earnings Growth?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

A Side By Side comparison of ECO Animal Health Group's Earnings Growth And 13% ROE

To start with, ECO Animal Health Group's ROE looks acceptable. Even when compared to the industry average of 13% the company's ROE looks quite decent. However, while ECO Animal Health Group has a pretty respectable ROE, its five year net income decline rate was 14% . So, there might be some other aspects that could explain this. For example, it could be that the company has a high payout ratio or the business has allocated capital poorly, for instance.

Next, when we compared with the industry, which has shrunk its earnings at a rate of 9.5% in the same period, we still found ECO Animal Health Group's performance to be quite bleak, because the company has been shrinking its earnings faster than the industry.

past-earnings-growth
past-earnings-growth

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if ECO Animal Health Group is trading on a high P/E or a low P/E, relative to its industry.

Is ECO Animal Health Group Using Its Retained Earnings Effectively?

With a high three-year median payout ratio of 72% (implying that 28% of the profits are retained), most of ECO Animal Health Group's profits are being paid to shareholders, which explains the company's shrinking earnings. With only a little being reinvested into the business, earnings growth would obviously be low or non-existent.

Moreover, ECO Animal Health Group has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 17% over the next three years. However, ECO Animal Health Group's future ROE is expected to decline to 4.5% despite the expected decline in its payout ratio. We infer that there could be other factors that could be steering the foreseen decline in the company's ROE.

Conclusion

Overall, we feel that ECO Animal Health Group certainly does have some positive factors to consider. However, while the company does have a high ROE, its earnings growth number is quite disappointing. This can be blamed on the fact that it reinvests only a small portion of its profits and pays out the rest as dividends. With that said, we studied the latest analyst forecasts and found that while the company has shrunk its earnings in the past, analysts expect its earnings to grow in the future. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.